Chemotherapeutic inhibition of the NLRP3 inflammasome was recently shown to inhibit CHIKV arthropathy in a mouse model [30]; the current study, therefore, confirms this pathway as a potential drug target in humans. This evidence concerns the gene NLRP3 and arthropathy.